Spanish translations of Miranda warnings and the totality of the circumstances

Autor: Lisa L. Hazelwood, Raquel C. Hoersting, Daniel W. Shuman, Amor A. Correa, Richard Rogers, Hayley L. Blackwood

Publikováno v: Law and Human Behavior. 33:61-69

Spanish-translated Miranda warnings are administered annually to thousands of Hispanic custodial suspects. In examining 121 Spanish translations and their English counterparts from 33 states, the lengths of Miranda warnings were generally comparable

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6272097024c3b733555f53e6bc35ce3
https://doi.org/10.1007/s10979-008-9129-9

The language of Miranda warnings in American jurisdictions: A replication and vocabulary analysis

Autor: Richard Rogers, Lisa L. Hazelwood, Kimberly S. Harrison, Kenneth W. Sewell, Daniel W. Shuman

Publikováno v: Law and Human Behavior. 32:124-136

Miranda warnings are remarkably heterogeneous in their language, length, and content. Past research has focused mostly on individual Miranda warnings. Lacking in generalizability, these studies have limited applicability to both public policy and pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f20482664f1a1339b9866607e4019aa
https://doi.org/10.1007/s10979-007-9091-y

The role of suggestibility in determinations of Miranda abilities: a study of the Gudjonsson Suggestibility Scales

Autor: Jill E. Rogstad, Lisa L. Hazelwood, Richard Rogers, Kimberly S. Harrison, Kathryn A. LaFortune

Publikováno v: Law and human behavior. 34(1)

Traditionally, high levels of suggestibility have been widely assumed to be linked with diminished Miranda abilities, especially in relationship to the voluntariness of waivers. The current investigation examined suggestibility on the Gudjonsson Sugg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f91b15ccfa216082cb537792c198d9
https://pubmed.ncbi.nlm.nih.gov/19462223

IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ.

Autor: Tan Y; AbbVie Cambridge Research Center, Cambridge, MA, United States., Mosallanejad K; AbbVie Cambridge Research Center, Cambridge, MA, United States., Zhang Q; AbbVie Cambridge Research Center, Cambridge, MA, United States., O'Brien S; AbbVie Bioresearch Center, Worcester, MA, United States., Clements M; AbbVie Bioresearch Center, Worcester, MA, United States., Perper S; AbbVie Bioresearch Center, Worcester, MA, United States., Wilson S; AbbVie Bioresearch Center, Worcester, MA, United States., Chaulagain S; AbbVie Cambridge Research Center, Cambridge, MA, United States., Wang J; AbbVie Bioresearch Center, Worcester, MA, United States., Abdalla M; AbbVie Bioresearch Center, Worcester, MA, United States., Al-Saidi H; AbbVie Inc., North Chicago, IL, United States., Butt D; AbbVie Bioresearch Center, Worcester, MA, United States., Clabbers A; AbbVie Bioresearch Center, Worcester, MA, United States., Ofori K; AbbVie Bioresearch Center, Worcester, MA, United States., Dillon B; AbbVie Bioresearch Center, Worcester, MA, United States., Harvey B; AbbVie Cambridge Research Center, Cambridge, MA, United States., Memmott J; AbbVie Bioresearch Center, Worcester, MA, United States., Negron C; AbbVie Bioresearch Center, Worcester, MA, United States., Winarta D; AbbVie Bioresearch Center, Worcester, MA, United States., Tan C; AbbVie Cambridge Research Center, Cambridge, MA, United States., Biswas A; AbbVie Cambridge Research Center, Cambridge, MA, United States., Dong F; AbbVie Cambridge Research Center, Cambridge, MA, United States., Morales-Tirado V; AbbVie Bioresearch Center, Worcester, MA, United States., Lu X; AbbVie Cambridge Research Center, Cambridge, MA, United States., Singh G; AbbVie Cambridge Research Center, Cambridge, MA, United States., White M; AbbVie Cambridge Research Center, Cambridge, MA, United States., Ashley S; AbbVie Inc., North Chicago, IL, United States., Knight H; AbbVie Bioresearch Center, Worcester, MA, United States., Westmoreland S; AbbVie Bioresearch Center, Worcester, MA, United States., Phillips L; AbbVie Bioresearch Center, Worcester, MA, United States., Carr T; AbbVie Inc., North Chicago, IL, United States., Reinke-Breen L; AbbVie Inc., North Chicago, IL, United States., Singh R; AbbVie Bioresearch Center, Worcester, MA, United States., Xu J; AbbVie Bioresearch Center, Worcester, MA, United States., Wu K; AbbVie Bioresearch Center, Worcester, MA, United States., Rinaldi L; AbbVie Bioresearch Center, Worcester, MA, United States., Stoll B; AbbVie Inc., North Chicago, IL, United States., He YD; AbbVie Inc., North Chicago, IL, United States., Hazelwood L; AbbVie Inc., North Chicago, IL, United States., Karman J; AbbVie Bioresearch Center, Worcester, MA, United States., McCluskey A; AbbVie Bioresearch Center, Worcester, MA, United States., Stine W; AbbVie Bioresearch Center, Worcester, MA, United States., Correia I; AbbVie Bioresearch Center, Worcester, MA, United States., Gauld S; AbbVie Inc., North Chicago, IL, United States., Levesque MC; AbbVie Cambridge Research Center, Cambridge, MA, United States., Veldman G; AbbVie Bioresearch Center, Worcester, MA, United States., Hubeau C; AbbVie Cambridge Research Center, Cambridge, MA, United States., Radstake T; AbbVie Cambridge Research Center, Cambridge, MA, United States., Sadhukhan R; AbbVie Bioresearch Center, Worcester, MA, United States., Fiebiger E; AbbVie Cambridge Research Center, Cambridge, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Feb 22; Vol. 15, pp. 1293883. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).

Serotonin 5-ht2 receptors: molecular and genomic diversity.

Autor: Sanders-Bush E; Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. elaine.bush@vanderbilt.edu, Fentress H, Hazelwood L

Publikováno v: Molecular interventions [Mol Interv] 2003 Sep; Vol. 3 (6), pp. 319-30.